Buys
Open market- Shares
- Avg price
- Total value
Marianne de Backer - President and CEO, Director at Vir Biotechnology, Inc.
Issuer-level insider activity
- Role
- President and CEO, Director
- Issuer ticker
- VIR on Nasdaq
- Entity type
- Individual
- Source filing history
- Open source filing history
Identity
Names, identifiers, and filing context for this profile.
1 identity field
Source evidence
Original filing metadata and source links for verification.
1 source field
Past-year transaction volume for Marianne de Backer in Vir Biotechnology, Inc.
Sells
Open market- Shares
- -106,360
- Avg price
- $8.90
- Total value
- -$946,964
Net
Past year- Shares
- -106,360
- Share %
- -100%
- Total value
- -$946,964
Reported holdings for Marianne de Backer in Vir Biotechnology, Inc.
Form 4 holding
President and CEO, Director
Vir Biotechnology, Inc.
- Security class
- Common Stock
- Shares / value
- 714,613
- Estimated value
- $6,402,932
- Report date
- 29 Apr 2026
- Price
- $8.96
- Ownership
- Direct
Form 4 holding
President and CEO, Director
Vir Biotechnology, Inc.
- Security class
- Common Stock
- Shares / value
- 286,650
- Estimated value
- $2,568,384
- Report date
- 29 Apr 2026
- Price
- $8.96
- Ownership
- Indirect
Form 4 holding
President and CEO, Director
Vir Biotechnology, Inc.
- Security class
- Stock Option (Right to Buy)
- Shares / value
- 570,000
- Estimated value
- $734,400
- Report date
- 22 Feb 2026
- Price
- $1.53
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
Transaction history for Marianne de Backer in Vir Biotechnology, Inc.
| Sym | Class | Transaction | % | SEC-reported value | SEC-reported price | Shares | Shares after | Date | Ownership |
|---|
* marks a reported price that did not pass the local price check.